The 5 categories in the cannabis sector perform quite differently from each other and below is a summary of how each category has performed month-to-date (MTD) in descending order and year-to-date (YTD):

1. The American Cannabis MSOs Index: down 4.4% MTD; down 8.2% YTD 
   • The Index consists of the 12 largest American Multi-State Operators, namely, Acreage (ACRDF/ACRHF); Ascend Wellness (AAWH); Ayr Wellness (AYRWF); Columbia Care (CCHWF); Cresco (CRLBF); Curaleaf (CURLF); Green Thumb (GTBIF);  Jushi (JUSHF); Planet 13 (PLNHF); TerrAscend (TRSSF); Trulieve (TCNNF) and Verano  (VRNOF).
2. The Conservative Pot Stocks Index: down 4.9% MTD; down 6.1% YTD
   • The Index consists of 6 tobacco, beer, and liquor companies that have invested heavily in the cannabis industry, namely, Altria Group (MO); Anheuser-Busch  (BUD); British American Tobacco (BTI); Constellation Brands (STZ);  Imperial Brands (IMBBY) and Molson Coors Brewing Company (TAP).
   • The constituent stocks all pay dividends with yields ranging from just 0.9% for Anheuser Busch to 8.4% for Altria and average out at 3.1%.
3. The Canadian Cannabis LPs Index: down 9.4% MTD; down 13.3% YTD
   • The Index consists of the 5 largest Canadian Licensed Producers, namely: Aurora (ACB); Canopy Growth (CGC); Cronos (CRON); Organigram (OGI), and Tilray (TLRY).
4. The Ancillary Pot Stock Index: down 12.2% MTD; up 0.4% YTD
   • The Index consists of the 7 largest companies providing goods and services to the cannabis sector, namely, AFC Gamma  (AFCG); Forian (FORA);  Hydrofarm (HYFM); GrowGeneration (GRWG); Innovative Industrial Properties (IIPR);  Scotts Miracle-Gro Company (SMG) and Turning Point Brands (TPB).
5. The Psychedelic Drug Stocks Index: down 14.3% MTD; down 10.2% YTD
   • The Index consists of 7 psychedelic compound-based and marijuana (THC) drug companies in the clinical stages of research and development of treatments for a wide variety of mental illnesses, namely Cybin (CYBN); Atai (ATAI); Seelos (SEEL), Compass Pathway (CMPS); Mind Medicine (MNMD), GH Resources (GHRS) and  Incannex Healthcare (IXHL), the newest addition to the list.

In summary, the 5 cannabis/cannabis-related company stock category performances ranged from: -4.4% to -14.3% YTD.

More By This Author:

An Update On The Performance Of The 7 Largest Psychedelic Stocks
The "Multi-Bagger" Portfolio: An Update
The "Rags-To-Riches" Portfolio: An Update